VERA
NASDAQ
US
Vera Therapeutics, Inc. - Class A Common Stock
$40.86
▲ +$0.36
(+0.89%)
Vol 707K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$3.5B
ROE
-50.9%
D/E
18.71
Beta
1.18
52W
$19–$56
Wall Street Consensus
20 analysts · Apr 20267
Strong Buy
11
Buy
2
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating
Price Chart
Similar Stocks
DYN
Dyne Therapeutics Inc
$3.2B
TNGX
Tango Therapeutics Inc
$1.2B
TWST
Twist Bioscience Corp
$1.9B
CPRX
Catalyst Pharmaceuticals Inc
P/E 13.2
$2.9B
ARQT
Arcutis Biotherapeutics Inc
$3.6B
IDYA
IDEAYA Biosciences Inc
$3.0B
TVTX
Travere Therapeutics Inc
$3.4B
ORKA
Oruka Therapeutics Inc
$1.5B
VCYT
Veracyte Inc
P/E 110.3
$3.3B
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-1.31 | $-1.39 | $-0.08 |
| Sep 2025 | $-1.16 | $-1.26 | $-0.10 |
| Jun 2025 | $-0.84 | $-1.20 | $-0.36 |
| Mar 2025 | $-0.75 | $-0.81 | $-0.06 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -46.7% | -46.7% | -46.7% | -46.7% | -50.9% | -50.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 15.90 | 15.90 | 15.90 | 15.90 | 18.71 | 18.71 |
| Current Ratio | 17.03 | 17.03 | 17.03 | 17.03 | 12.21 | 12.21 |
Key Ratios
ROA (TTM)
-42.7%
P/B
4.6
EPS (TTM)
$-3.98
52W High
$56.05
52W Low
$18.53
$18.53
52-Week Range
$56.05
How does VERA compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
VERA valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
4.6
▲
89%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
VERA profitability vs Biotechnology peers
ROE
-50.9%
▲
24%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-42.7%
▲
9%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
VERA financial health vs Biotechnology peers
D/E ratio
18.7
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
12.2
▲
175%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.2
▲
21%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
VERA fundamentals radar
VERA
Peer median
Industry
VERA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
VERA vs peers: key metrics
Latest News
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating
Yahoo Finance · Apr 04
Several vessels, including French container ship, pass through strait of Hormuz
The Guardian · Apr 03
Rogers Communications Breaks Below 200-Day Moving Average - Notable for RCI
Nasdaq · Apr 03
Nvidia Is Fast Approaching Its 20-Day Moving Average. Is a Comeback Brewing?
Yahoo Finance · Apr 03
Nat-Gas Prices Pressured by Above-Average US Temps
Yahoo Finance · Apr 02